Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botox for Neurogenic Overactive Bladder with Respiratory Impairment
NCT00439140Phase 3Terminated
- Sponsor
- Allergan
- Start
- Jun 2007
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 4
01
Overview
A Phase 3 trial of onabotulinumtoxinA in Neurogenic Bladder (NB), sponsored by Allergan. Started Jun 2007; status: terminated.
02
Drugs
onabotulinumtoxinA
03
Conditions
Neurogenic Bladder (NB)
Beyond the preview
Go deeper on NCT00439140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00439140.